Innovative AID System Set to Transform Diabetes Management
Revolutionizing Diabetes Management with Integrated Technologies
In an exciting development in the field of diabetes care, Sequel Med Tech, LLC has forged a partnership with Senseonics Holdings, Inc. Together, they are set to introduce the first Automated Insulin Delivery (AID) system that works seamlessly with the one-year Continuous Glucose Monitor (CGM), known as Eversense 365. This innovative collaboration is designed to enhance the quality of life for people living with type 1 diabetes by providing advanced tools for diabetes management.
Understanding the twiist AID System
The twiist Automated Insulin Delivery System is a groundbreaking advancement in insulin management, specifically engineered to cater to the unique needs of individuals with type 1 diabetes. Unlike conventional insulin delivery systems, twiist is capable of measuring insulin doses accurately with every micro-dose delivered. This precision is critical for adapting to the fluctuating needs of diabetes management.
How the twiist System Works
Cleared for use in individuals aged six and older, the twiist system incorporates an advanced algorithm known as the twiist Loop, which is derived from the community-driven Tidepool Loop. This algorithm efficiently adjusts basal insulin deliveries based on real-time readings from the CGM and predictive calculations of glucose levels.
Partnership with Senseonics
Through this strategic partnership with Senseonics, the twiist AID system will integrate with the Eversense 365 CGM system, a device that has set a new benchmark in glucose monitoring by offering one year of continuous monitoring. This integration represents a significant leap forward in diabetes technology, offering users enhanced flexibility and personalization in their care routines.
A Flexible Solution for Diabetes Management
Patients utilizing the twiist AID system will have the option to select from two CGM partners: the Eversense 365 and Abbott’s FreeStyle Libre 3 Plus sensor, allowing for tailored management strategies that best fit their individual lifestyles and health needs. This choice empowers users, giving them greater control over their diabetes treatment plan.
The Significance of the Eversense 365 CGM
Eversense 365 is distinct in the market, being the only implantable CGM that provides continuous glucose monitoring for a full year. This innovative approach minimizes the common challenges associated with short-term CGMs, such as frequent sensor replacements and interruptions in care. By utilizing Eversense 365, patients can focus on managing their diabetes without the added stress of constant monitoring equipment changes.
Benefits for Patients and Care Teams
This collaboration not only enhances patient experience but also equips healthcare professionals with reliable data, ultimately improving decision-making abilities. The integration of twiist and Eversense 365 has been optimized to simplify diabetes care and improve the quality of life for those diagnosed with the condition.
Looking Ahead: Launch Plans
Anticipated for launch in the third quarter of this year, the twiist AID system with Eversense 365 integration is set to revolutionize diabetes management. Both companies are committed to pushing the boundaries of what technology can offer in this essential area of healthcare.
A Commitment to Innovation
Sequel Med Tech remains dedicated to advancing diabetes technology and expanding its partnerships to empower individuals managing diabetes. Their ongoing innovations highlight a concerted effort to transform the landscape of diabetes care, paving the way for a future of enhanced accessibility to reliable and effective management tools.
Frequently Asked Questions
What makes the twiist AID system unique?
The twiist AID system uniquely measures every micro-dose of insulin delivered, allowing for precise insulin management tailored to each individual’s needs.
How does Eversense 365 CGM improve diabetes care?
Eversense 365 provides continuous glucose monitoring for up to one year, reducing the frequency of sensor replacements and interruptions, which greatly enhances user experience.
What are the benefits of integrating twiist with Eversense 365?
This integration allows for a personalized and flexible diabetes management system, offering patients enhanced control and a better quality of life.
Who can use the twiist AID system?
The twiist AID system is currently cleared for individuals aged six years and older with type 1 diabetes.
When will the integrated system be available to patients?
The launch of the integrated twiist AID system with Eversense 365 is expected in the third quarter of this year.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.